Compare FedEx Corporation (FDX) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FedEx Corporation vs 10X Genomics Inc — how do they compare? FedEx Corporation trades at $322.43 (market cap $76.28B), while 10X Genomics Inc trades at $59.24 (market cap $7.61B). The key difference: FedEx Corporation is far larger — about 10× 10X Genomics Inc's market cap, and FedEx Corporation pays a 1.51% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| FDX | TXG | |
|---|---|---|
Market Cap | $76.28B | $7.61B |
Sector | Industrials | Health |
52-Week High | $338.75 | $58.57 |
52-Week Low | $180.51 | $11.34 |
Enterprise Value | $105.91B | $7.14B |
Dividend Yield | 1.51% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FedEx Corporation
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
